Advertisement

Extracorporeal Shockwave Therapy and Knee Osteoarthritis: Defining a Placebo Group

      In the recently published study by Zhong et al, “A Randomized Controlled Trial on the Effects of Low-Dose Extracorporeal Shockwave Therapy in Patients With Knee Osteoarthritis,” the researchers studied low-dose extracorporeal shockwave therapy (ESWT) treatment in patients with knee osteoarthritis. They stated that ESWT was superior to placebo in both pain and functional improvement, as well as in terms of negative effects on the articular cartilage.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schmitz C.
        • Császár N.B.
        • Milz S.
        • et al.
        Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database.
        Br Med Bull. 2015; 116: 115
        • Li T.
        • Ma J.
        • Zhao T.
        • Gao F.
        • Sun W.
        Application and efficacy of extracorporeal shockwave treatment for knee osteoarthritis: a systematic review and meta-analysis.
        Exp Ther Med. 2019; 18: 2843-2850
        • Rompe J.D.
        • Decking J.
        • Schoellner C.
        • Theis C.
        Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players.
        Am J Sports Med. 2004; 32: 734-743
        • Speed C.
        A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence.
        Br J Sports Med. 2014; 48: 1538-1542

      Linked Article